CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for ABBVIE INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 5, 2026

Lobbying activity 2

Health Issues

International tax issues and pharmaceutical pricing and access issues, and patent issues.

Taxation/Internal Revenue Code

International tax issues and pharmaceutical pricing and access issues, and patent issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.